© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
June 26, 2018
Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.
Bringing Hope and Healing to Patients With Cancer
Discussing the Importance of Genetic Counseling in Women’s Cancer
Addressing Barriers to Care, Improving Access in Women’s Cancers
Transitioning from Active Care to Survivorship in Women’s Cancer